The Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and Management

This publication has 79 references indexed in Scilit:

• Abstract A25: Public and provider awareness and use of a CA-125 test for ovarian cancer
  Cancer Prevention Research, 2010
• Microglia: a newly discovered role in visceral hypersensitivity?
  Neuron Glia Biology, 2006
• Alvimopan, a selective peripherally acting μ‐opioid antagonist*
  Neurogastroenterology & Motility, 2005
• Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience
  The American Journal on Addictions, 2004
• Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
  New England Journal of Medicine, 2003
• Opioid-Induced Bowel Dysfunction
  Drugs, 2003
• Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability
  Pain, 2000
• The Opioid-Sparing Effects of Intravenous Ketorolac as an Adjuvant Analgesic in Cancer Pain
  Journal of Pain and Symptom Management, 1998
• Randomised trial of oral morphine for chronic non-cancer pain
  The Lancet, 1996
• Self-efficacy and the stages of self-change of smoking
  Cognitive Therapy and Research, 1985